Search - tctmd.com

Displaying 121 - 140 of 209

Sort: Relevancy | Date

News Daily News

A-fib Common After Aortic Valve Replacement

Jason Kahn

January 30, 2014

Presentation TCT 2013

TCT-117. Quality of Life Outcomes Among High-Risk Patients Undergoing TAVR via the Transapical Approach: A PARTNER Continued Access Substudy

Presenter: Ajay Kirtane

October 29, 2013

Presentation TCT 2013

Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 29, 2013

Presentation TCT 2013

Is There Still a Role for Alternative Access in TAVR (Transapical, Other)?

Presenter: Thomas Walther

October 29, 2013

News Conference News TCT 2013

Opportunities Exist to Improve Outcomes in Transapical TAVR

October 29, 2013

News Daily News

Transfemoral Access Not Only Option for TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

El Abordaje Transfemoral No es la Única Opción para la TAVR

Yael L. Maxwell

October 04, 2013

News Industry News

Edwards Receives IDE for US Clinical Trial of SAPIEN 3 Transcatheter Valve

August 05, 2013

News Industry News

Edwards Lifesciences Receives Approval for SAPIEN XT in Japan

June 24, 2013

Presentation TVT 2013

Transapical Approach: Advantages, Disadvantages, and How I Do It

Presenter: Thomas Walther

June 13, 2013

News Daily News

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Yael L. Maxwell

May 13, 2013

News Conference News SCAI 2013

Live TAVR Cases Pose No Additional Risk for Patients

L.A. McKeown

May 10, 2013

News Conference News AATS 2013

Promising Early Valve-in-Valve Results Seen in Small Nordic Registry

L.A. McKeown

May 07, 2013

News Daily News

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Jason Kahn

April 12, 2013

News Daily News

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Yael L. Maxwell

April 12, 2013

News Daily News

Pequeño estudio apoya TAVR transaórtica como mejor opción que la transapical

Jason Kahn

April 12, 2013

News Daily News

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

April 12, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

Presentation TCT 2013

Validation of Transapical Access Accuracy of Computed Tomographic Angiography-Fluoroscopy Fusion Guided Structural Heart Disease Interventions

Presenter: Bryce Einhorn, Sonnit Sharma, Francisco Cuesta, Chad Kliger, Bart Carelsen, Vladimir Jelnin, Howard Cohen, Greg Fontana, Carlos Ruiz

January 31, 2013

Presentation TCT 2013

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger, Bryce Einhorn, Vladimir Jelnin, Leandro Maranan, Gila Perk, itzhak kronzon, Howard Cohen, Carlos Ruiz

January 31, 2013

Advertisement

A-fib Common After Aortic Valve Replacement

TCT-117. Quality of Life Outcomes Among High-Risk Patients Undergoing TAVR via the Transapical Approach: A PARTNER Continued Access Substudy

Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions

Is There Still a Role for Alternative Access in TAVR (Transapical, Other)?

Opportunities Exist to Improve Outcomes in Transapical TAVR

Transfemoral Access Not Only Option for TAVR

El Abordaje Transfemoral No es la Única Opción para la TAVR

Edwards Receives IDE for US Clinical Trial of SAPIEN 3 Transcatheter Valve

Edwards Lifesciences Receives Approval for SAPIEN XT in Japan

Transapical Approach: Advantages, Disadvantages, and How I Do It

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Live TAVR Cases Pose No Additional Risk for Patients

Promising Early Valve-in-Valve Results Seen in Small Nordic Registry

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Pequeño estudio apoya TAVR transaórtica como mejor opción que la transapical

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Validation of Transapical Access Accuracy of Computed Tomographic Angiography-Fluoroscopy Fusion Guided Structural Heart Disease Interventions

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content